Our client is a Swiss multinational healthcare company that operates under the divisions of Pharmaceuticals and Diagnostics worldwide. Headquartered in Basel, our client is the largest pharmaceutical company in the world and the leading provider of cancer treatments globally. The client asked Greenland to carry out market research that could help them understand perceptions of the current and potential customers of Metered Dose Inhalers. The study also aimed at evaluating these inhalers as the key revenue generators in Asthma therapeutic market and identify the current unmet needs in the Inhaler market. The client required this data for 4 countries in total: UAE, USA, Brazil, and Russia. Therefore, within the short time of a week, 95 telephonic interviews were conducted with the current and prospective Metered Dose Inhaler users in these countries and the responses had been recorded.